A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

Clinical trial NCT03879135 · COMPLETED

Trial details

NCT number: NCT03879135
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD)

Start date: 2019-04-01
Primary completion: 2025-01-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.